CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

tozuleristide

PeptideexperimentalImaging agent

Clinical trial activity

9 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
6
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Dec 1, 2013 (NCT02097875)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • blz-100
  • blz-100

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05316688Phase 1/Phase 2 (Phase 2)Mar 5, 2023Blaze Bioscience Inc., University of Washington
NCT04743310Phase 2Sep 30, 2021Blaze Bioscience Inc., Cedars-Sinai Medical Center
NCT03579602Phase 2/Phase 3 (Phase 3)Aug 31, 2018Blaze Bioscience Inc., The Pacific Pediatric Neuro-Oncology Consortium
NCT02464332Phase 1Sep 1, 2015Blaze Bioscience Inc., Cedars-Sinai Medical Center, National Cancer Institute (NCI)
NCT02496065Phase 1Jul 1, 2015Blaze Bioscience Inc., Overlake Medical Center
NCT02462629Phase 1Jun 1, 2015Blaze Bioscience Inc., University of Washington
NCT02234297Phase 1Oct 1, 2014Blaze Bioscience Inc., Cedars-Sinai Medical Center
NCT02097875Phase 1Dec 1, 2013Blaze Bioscience Inc., Veracity Clinical Research
NCT04343274N/A—Blaze Bioscience Inc.
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Blaze Bioscience Inc.For profit9742013
Cedars-Sinai Medical CenterAcademic/Hospital3122014
University of WashingtonAcademic/Hospital2122015
National Cancer Institute (NCI)Government1012015
Overlake Medical CenterAcademic/Hospital1012015
The Pacific Pediatric Neuro-Oncology ConsortiumAcademic/Hospital1012018
Veracity Clinical ResearchFor profit1012013
7 organizations
Page 1 / 1